Palliative Care Market by Condition (Cardiovascular Diseases, Cancer, Chronic Respiratory Diseases, and Others), Age Group (Adult and Pediatric), and Provider (Hospitals & Clinics, Nursing Homes, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030
- ALL4676717
- 208 Pages
- August 2021
- Medical Devices
Palliative care improves quality of life of patients and their families who are facing problems associated with life-threatening diseases, whether psychological, physical, social or spiritual. Palliative care involves a range of services provided by a range of professionals that all have similarly vital roles to play. These professionals include nursing, paramedics, physicians, pharmacists, physiotherapists, support workers, and healthcare volunteers in support of patient and their family. The early delivery of palliative care minimizes avoidable hospital admissions and the need of health services.
The growth of the palliative care market is driven by increase in incidences of life-threatening diseases such as cardiovascular diseases, cancer, chronic respiratory diseases, and others, rise in elderly population, and technological advancements for remote monitoring in the healthcare industry. In addition, rise in awareness of life-threatening conditions, increase in need of providing palliative care sectors in hospitals & clinics, rise in number of palliative care centers worldwide, increase in application of palliative care for homecare, and surge in number of qualified physicians for palliative care are expected to boost the market growth during the forecast period. However, lack of access to palliative care services in underdeveloped countries is expected to hamper the market growth during the forecast period. Conversely, high market growth potential in emerging markets is expected to offer lucrative opportunities during the forecast period.
The palliative care market is segmented into condition, age group, provider, and region. On the basis of condition, the market is categorized into cardiovascular diseases, cancer, chronic respiratory diseases, and others. By age group, the market is bifurcated into adult and pediatric. The adult segment is further segmented into hospitals & clinics, nursing homes, and others. The pediatric segment is further segmented into hospitals & clinics, nursing homes, and others. On the basis of provider, the market is divided into hospitals & clinics, nursing homes, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers a quantitative analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
• A comprehensive analysis of four regions is provided to determine the existing opportunities.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
By Condition
• Cardiovascular Diseases
• Cancer
• Chronic Respiratory Diseases
• Others
By Age Group
• Adult
o Hospitals & Clinics
o Nursing Homes
o Others
• Pediatric
o Hospitals & Clinics
o Nursing Homes
o Others
By Provider
• Hospitals & Clinics
• Nursing Homes
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
• Amedisys, Inc.
• Chemed Corporation (Vitas Healthcare)
• Fillmore Capital Partners, LLC (Golden Living Centers/GGNSC Holdings LLC)
• Genesis HealthCare (Skilled Healthcare Group Inc.)
• Home Instead, Inc.
• Kindred Healthcare, LLC (Gentiva Health Services Inc.)
• Public Sector Pension Investment Board (Sunrise Senior Living Centers)
• Senior Care Centers of America, Inc
• Seymour Health
• UCLA Health
1.1.Report description
1.2.Key Benefits for Stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Rise in incidence of life-threatening diseases
3.5.1.2.Increase in geriatric population
3.5.1.3.Increase in government expenditure on healthcare
3.5.2.Restraint
3.5.2.1.lack of access to palliative care services in underdeveloped countries
3.5.3.Opportunities
3.5.3.1.High market growth potential in emerging markets
3.5.4.Impact analysis
3.6.Covid-19 Impact analysis on palliative care market
CHAPTER 4:PALLIATIVE CARE MARKET, BY CONDITION
4.1.Overview
4.1.1.Market size and forecast
4.2.Cardiovascular diseases
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Cancer
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.4.Chronic respiratory diseases
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
4.5.Others
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country
CHAPTER 5:PALLIATIVE CARE MARKET, BY AGE GROUP
5.1.Overview
5.1.1.Market size and forecast
5.2.Adults
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.2.3.Market size and forecast, by provider
5.3.Pediatric
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.3.3.Market size and forecast, by provider
CHAPTER 6:PALLIATIVE CARE MARKET, BY PROVIDER
6.1.Overview
6.1.1.Market size and forecast
6.2.Hospitals & clinics
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.3.Nursing homes
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
6.4.Others
6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country
CHAPTER 7:PALLIATIVE CARE MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country
7.2.2.1.U.S.
7.2.2.1.1.U.S. palliative care market, by condition
7.2.2.1.2.U.S. palliative care market, by age group
7.2.2.1.3.U.S. palliative care market, by provider
7.2.2.2.Canada
7.2.2.2.1.Canada palliative care market, by condition
7.2.2.2.2.Canada palliative care market, by age group
7.2.2.2.3.Canada palliative care market, by provider
7.2.2.3.Mexico
7.2.2.3.1.Mexico palliative care market, by condition
7.2.2.3.2.Mexico palliative care market, by age group
7.2.2.3.3.Mexico palliative care market, by provider
7.2.3.North America market size and forecast, by condition
7.2.4.North America market size and forecast, by age group
7.2.5.North America market size and forecast, by provider
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country
7.3.2.1.Germany
7.3.2.1.1.Germany palliative care market, by condition
7.3.2.1.2.Germany palliative care market, by age group
7.3.2.1.3.Germany palliative care market, by provider
7.3.2.2.France
7.3.2.2.1.France palliative care market, by condition
7.3.2.2.2.France palliative care market, by age group
7.3.2.2.3.France palliative care market, by provider
7.3.2.3.UK
7.3.2.3.1.UK palliative care market, by condition
7.3.2.3.2.UK palliative care market, by age group
7.3.2.3.3.UK palliative care market, by provider
7.3.2.4.Italy
7.3.2.4.1.Italy palliative care market, by condition
7.3.2.4.2.Italy palliative care market, by age group
7.3.2.4.3.Italy palliative care market, by provider
7.3.2.5.Spain
7.3.2.5.1.Spain palliative care market, by condition
7.3.2.5.2.Spain palliative care market, by age group
7.3.2.5.3.Spain palliative care market, by provider
7.3.2.6.Rest of Europe
7.3.2.6.1.Rest of Europe palliative care market, by condition
7.3.2.6.2.Rest of Europe palliative care market, by age group
7.3.2.6.3.Rest of Europe palliative care market, by provider
7.3.3.Europe market size and forecast, by condition
7.3.4.Europe market size and forecast, by age group
7.3.5.Europe market size and forecast, by provider
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country
7.4.2.1.Japan
7.4.2.1.1.Japan palliative care market, by condition
7.4.2.1.2.Japan palliative care market, by age group
7.4.2.1.3.Japan palliative care market, by provider
7.4.2.2.China
7.4.2.2.1.China palliative care market, by condition
7.4.2.2.2.China palliative care market, by age group
7.4.2.2.3.China palliative care market, by provider
7.4.2.3.Australia
7.4.2.3.1.Australia palliative care market, by condition
7.4.2.3.2.Australia palliative care market, by age group
7.4.2.3.3.Australia palliative care market, by provider
7.4.2.4.India
7.4.2.4.1.India palliative care market, by condition
7.4.2.4.2.India palliative care market, by age group
7.4.2.4.3.India palliative care market, by provider
7.4.2.5.South Korea
7.4.2.5.1.South Korea palliative care market, by condition
7.4.2.5.2.South Korea palliative care market, by age group
7.4.2.5.3.South Korea palliative care market, by provider
7.4.2.6.Rest of Asia-Pacific
7.4.2.6.1.Rest of Asia-Pacific palliative care market, by condition
7.4.2.6.2.Rest of Asia-Pacific palliative care market, by age group
7.4.2.6.3.Rest of Asia-Pacific palliative care market, by provider
7.4.3.Asia-Pacific market size and forecast, by condition
7.4.4.Asia-Pacific market size and forecast, by age group
7.4.5.Asia-Pacific market size and forecast, by provider
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country
7.5.2.1.Brazil
7.5.2.1.1.Brazil palliative care market, by condition
7.5.2.1.2.Brazil palliative care market, by age group
7.5.2.1.3.Brazil palliative care market, by provider
7.5.2.2.Saudi Arabia
7.5.2.2.1.Saudi Arabia palliative care market, by condition
7.5.2.2.2.Saudi Arabia palliative care market, by age group
7.5.2.2.3.Saudi Arabia palliative care market, by provider
7.5.2.3.South Africa
7.5.2.3.1.South Africa palliative care market, by condition
7.5.2.3.2.South Africa palliative care market, by age group
7.5.2.3.3.South Africa palliative care market, by provider
7.5.2.4.Rest of LAMEA
7.5.2.4.1.Rest of LAMEA palliative care market, by condition
7.5.2.4.2.Rest of LAMEA palliative care market, by age group
7.5.2.4.3.Rest of LAMEA palliative care market, by provider
7.5.3.LAMEA market size and forecast, by condition
7.5.4.LAMEA market size and forecast, by age group
7.5.5.LAMEA market size and forecast, by provider
CHAPTER 8:COMPANY PROFILES
8.1.Amedisys, Inc.
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments
8.2.Chemed Corporation (Vitas Healthcare)
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments
8.3.Fillmore Capital Partners, LLC (Golden Living Centers/GGNSC Holdings LLC)
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.4.Genesis HealthCare (Skilled Healthcare Group Inc.
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.5.Home Instead, Inc.
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Key strategic moves and developments
8.6.Kindred Healthcare, LLC (Gentiva Health Services Inc.)
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Key strategic moves and developments
8.7.Public Sector Pension Investment Board (Sunrise Senior Living Centers)
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments
8.8.SENIOR CARE CENTERS OF AMERICA, INC
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Key strategic moves and developments
8.9.Seymour Health
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.10.University of California (UCLA Health)
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
TABLE 01.PALLIATIVE CARE MARKET, BY CONDITION, 2020-2030 ($MILLION)
TABLE 02.PALLIATIVE CARE MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2020-2030 ($MILLION)
TABLE 03.PALLIATIVE CARE MARKET FOR CANCER, BY REGION, 2020-2030 ($MILLION)
TABLE 04.PALLIATIVE CARE MARKET FOR CHRONIC RESPIRATORY DISEASES, BY REGION, 2020-2030 ($MILLION)
TABLE 05.PALLIATIVE CARE MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 06.PALLIATIVE CARE MARKET, BY AGE GROUP, 2020-2030 ($MILLION)
TABLE 07.PALLIATIVE CARE MARKET FOR ADULTS, BY REGION, 2020-2030 ($MILLION)
TABLE 08.PALLIATIVE CARE MARKET FOR ADULTS, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 09.PALLIATIVE CARE MARKET FOR PEDIATRIC, BY REGION, 2020-2030 ($MILLION)
TABLE 10.PALLIATIVE CARE MARKET FOR PEDIATRIC, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 11.PALLIATIVE CARE MARKET, BY PROVIDER, 2020-2030 ($MILLION)
TABLE 12.PALLIATIVE CARE MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020-2030 ($MILLION)
TABLE 13.PALLIATIVE CARE MARKET FOR NURSING HOMES, BY REGION, 2020-2030 ($MILLION)
TABLE 14.PALLIATIVE CARE MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 15.PALLIATIVE CARE MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 16.NORTH AMERICA PALLIATIVE CARE MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 17.U.S. PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 18.U.S. PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 19.U.S. PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 20.CANADA PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 21.CANADA PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 22.CANADA PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 23.MEXICO PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 24.MEXICO PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 25.MEXICO PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 26.NORTH AMERICA PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 27.NORTH AMERICA PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 28.NORTH AMERICA PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 29.EUROPE PALLIATIVE CARE MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 30.GERMANY PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 31.GERMANY PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 32.GERMANY PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 33.FRANCE PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 34.FRANCE PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 35.FRANCE PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 36.UK PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 37.UK PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 38.UK PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 39.ITALY PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 40.ITALY PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 41.ITALY PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 42.SPAIN PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 43.SPAIN PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 44.SPAIN PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 45.REST OF EUROPE PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 46.REST OF EUROPE PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 47.REST OF EUROPE PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 48.EUROPE PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 49.EUROPE PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 50.EUROPE PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 51.ASIA-PACIFIC PALLIATIVE CARE MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 52.JAPAN PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 53.JAPAN PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 54.JAPAN PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 55.CHINA PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 56.CHINA PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 57.CHINA PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 58.AUSTRALIA PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 59.AUSTRALIA PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 60.AUSTRALIA PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 61.INDIA PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 62.INDIA PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 63.INDIA PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 64.SOUTH KOREA PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 65.SOUTH KOREA PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 66.SOUTH KOREA PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 67.REST OF ASIA-PACIFIC PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 68.REST OF ASIA-PACIFIC PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 69.REST OF ASIA-PACIFIC PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 70.ASIA-PACIFIC PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 71.ASIA-PACIFIC PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 72.ASIA-PACIFIC PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 73.LAMEA PALLIATIVE CARE MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 74.BRAZIL PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 75.BRAZIL PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 76.BRAZIL PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 77.SAUDI ARABIA PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 78.SAUDI ARABIA PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 79.SAUDI ARABIA PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 80.SOUTH AFRICA PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 81.SOUTH AFRICA PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 82.SOUTH AFRICA PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 83.REST OF LAMEA PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 84.REST OF LAMEA PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 85.REST OF LAMEA PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 86.LAMEA PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 87.LAMEA PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 88.LAMEA PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 89.AMEDISYS: COMPANY SNAPSHOT
TABLE 90.AMEDISYS: OPERATING SEGMENTS
TABLE 91.AMEDISYS: PRODUCT PORTFOLIO
TABLE 92.AMEDISYS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 93.CHEMED: COMPANY SNAPSHOT
TABLE 94.CHEMED: OPERATING SEGMENTS
TABLE 95.CHEMED: PRODUCT PORTFOLIO
TABLE 96.CHEMED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 97.FCP: COMPANY SNAPSHOT
TABLE 98.FCP: OERATING SEGMENT
TABLE 99.FCP: PRODUCT PORTFOLIO
TABLE 100.GENESIS: COMPANY SNAPSHOT
TABLE 101.GENESIS: OPERATING SEGMENTS
TABLE 102.GENESIS: PRODUCT PORTFOLIO
TABLE 103.HOME INSTEAD: COMPANY SNAPSHOT
TABLE 104.HOME INSTEAD: OERATING SEGMENT
TABLE 105.HOME INSTEAD.: PRODUCT PORTFOLIO
TABLE 106.HOME INSTEAD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 107.KINDRED HEALTHCARE: COMPANY SNAPSHOT
TABLE 108.KINDRED HEALTHCARE: OPERATING SEGMENTS
TABLE 109.KINDRED HEALTHCARE: PRODUCT PORTFOLIO
TABLE 110.KINDRED HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 111.PSP INVESTMENTS: COMPANY SNAPSHOT
TABLE 112.PSP INVESTMENTS: OPERATING SEGMENTS
TABLE 113.PSP INVESTMENTS: PRODUCT PORTFOLIO
TABLE 114.PSP INVESTMENTS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 115.SENIOR CARE CENTERS OF AMERICA: COMPANY SNAPSHOT
TABLE 116.SENIOR CARE CENTERS OF AMERICA: OERATING SEGMENT
TABLE 117.SENIOR CARE CENTERS OF AMERICA: PRODUCT PORTFOLIO
TABLE 118.SENIOR CARE CENTERS OF AMERICA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 119.SEYMOUR: COMPANY SNAPSHOT
TABLE 120.SEYMOUR: OPERATING SEGMENTS
TABLE 121.SEYMOUR: PRODUCT PORTFOLIO
TABLE 122.UC: COMPANY SNAPSHOT
TABLE 123.UC: OPERATING SEGMENTS
TABLE 124.UC: PRODUCT PORTFOLIO
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
